InvestorsHub Logo
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

Re: None

Wednesday, 08/08/2018 10:00:43 AM

Wednesday, August 08, 2018 10:00:43 AM

Post# of 205097
My educated guess: OvaDx is the test that Arrayit submitted to the FDA.
No other Arrayit test is at the stage for consideration for FDA approval.

In their last conference call in 2015 they said "Our Sunnyvale laboratories have more than adequate capacity to process 150,000 OvaDx® tests per year upon FDA approval" (at $650/test)

In the tweet on 7/3/18 after the FDA meeting, Mark was confident that the test will get FDA approval:

Jul 3
Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.

All IMO.